Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Quality of life in stage II breast cancer: an instrument for clinical trialsM N Levine, G H Guyatt, M Gent, et al.Cancer|May 1, 1984
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma GroupH M Pinedo, V H Bramwell, H T Mouridsen, et al.The New England Journal of Medicine|December 9, 1993
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphomaR M Meyer, I C Quirt, J R Skillings, et al.European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcomaE Gortzak, A Azzarelli, J Buesa, et al.Lancet (London, England)|October 7, 1997
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma IntergroupR L Souhami, A W Craft, J W Van der Eijken, et al.Sarcoma|January 1, 1997
A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study of the European Osteosarcoma IntergroupV H Bramwell, M V Burgers, R L Souhami, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials GroupM N Levine, V H Bramwell, K I Pritchard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site GroupK I Pritchard, A H Paterson, S Fine, et al.Pageof 5